www.med-genesis.com
Click here to view a searchable, detailed profile of this and the many other life sciences organizations across the province on the LifeSciences BC directory powered by flintbox.
For a national directory of life sciences organizations, click here
Address:
MedGenesis Therapeutix Inc.
730 – 730 View Street
Victoria, British Columbia
V8W 3Y7
Tel: 250-386-3000
Email: info@MedGenesis.com
Member Sector: Biopharmaceuticals
MedGenesis Therapeutix Inc. is a privately-held biopharmaceutical company developing and commercializing innovative treatments for patients with serious neurologic diseases.
The MedGenesis Convection Enhanced Delivery (CED) platform is a potentially disruptive technology which integrates cutting edge technical and development know-how and intellectual property. Led by Dr. Erich Mohr, a recognized expert in neuro-degenerative disorders, MedGenesis is the first and only CED-focused company worldwide.
Primary target indications for MedGenesis Therapeutix are Parkinson's disease, intractable epilepsy, and GBM. These indications are natural targets for CED-based treatment regimens because of the high unmet medical need, specific blood-brain-barrier challenges, and the invasiveness of the diagnostic and therapeutic armentarium that is currently available to patients.
The MedGenesis proprietary CED platform creates a unique, comprehensive patent-protected platform leaving MedGenesis without direct competitors at this time. MedGenesis has supplier relationships with two of the world’s leading companies in the area of medical devices which completes MedGenesis' leadership in this field.